Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CP✓SelectedUSD · CPMRNA vs CP performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs CP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-31.0%
CP return
+24.5%
Excess return
-55.5%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioCPExcessAlpha
1D-2.2%-1.7%-0.4%-1.2%
7D-12.7%-4.6%-8.1%-10.3%
30D-20.7%+2.0%-22.6%-21.8%
3M+46.3%-5.1%+51.3%+50.1%
6M+305.2%+4.5%+300.8%+291.0%
YTD+561.2%+22.8%+538.5%+473.2%
1Y+772.1%+31.2%+740.8%+625.9%
3Y+147.0%+28.3%+118.6%+114.2%
All-31.0%+24.5%-55.5%-39.5%

Cumulative growth

Daily Returns

Daily percentage return beside CP.

Daily Out/Under-Performance

Portfolio return minus CP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded CP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling